Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this Phase 3 study is to evaluate overall survival and progression free
survival following intravenous administration of REOLYSIN (Reovirus Serotype 3 Dearing) in
combination with paclitaxel and carboplatin versus chemotherapy treatment alone, in patients
with metastatic or recurrent Squamous Cell Carcinoma of the Head and Neck.